High Flow Ventilators Market Report 2025

The high flow ventilators market size has grown strongly in recent years. It will grow from $33.97 billion in 2024 to $36.97 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to enhanced monitoring and control systems, a growing geriatric population, expansion in home healthcare, demand in emergency medicine, and applications in postoperative care.

The high flow ventilators market size is expected to see rapid growth in the next few years. It will grow to $58.21 billion in 2029 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to a focus on non-invasive ventilation, neonatal and pediatric care demand, improved humidification systems, expansion in home healthcare settings, and emergency medicine utilization. Major trends in the forecast period include customization and versatility, focus on patient comfort, integration of monitoring technology, home-based high-flow ventilation, and adoption in critical care settings.

The anticipated increase in the prevalence of chronic obstructive pulmonary disease (COPD) is set to drive the growth of the high-flow ventilators market in the future. COPD, a chronic inflammatory lung disease, poses challenges to breathing and is characterized by irreversible airflow limitation that typically progresses over time. High-flow ventilators play a crucial role in COPD management by enhancing oxygenation, reducing the workload of breathing, and offering positive end-expiratory pressure, particularly during exacerbations or instances requiring advanced respiratory support. As of March 2023, data from the Scottish Public Health Observatory revealed a rise in COPD rates, with an upward trend seen in both males (from 83.2 to 97.6 cases per 100,000 new cases) and females (from 72.6 to 97.3) for the financial year 2021 to 2022. This upward trend follows the easing of the COVID-19 impact, indicating that the increasing prevalence of COPD will be a driving force for the growth of the high-flow ventilators market.

The increasing aging population is expected to contribute to the growth of the high-flow ventilators market. An aging population refers to a demographic shift characterized by a rising proportion of elderly individuals within a society over time. High-flow ventilators offer non-invasive respiratory support for elderly individuals, addressing age-related respiratory challenges with enhanced comfort and adaptability. According to the World Health Organization's October 2022 projections, by the year 2030, 1 out of every 6 individuals globally will be 60 years old or older. During this period, the proportion of the population aged 60 and over is expected to increase from 1 billion in 2020 to 1.4 billion. Moreover, the global population of individuals aged 60 and older is projected to double, reaching 2.1 billion by the year 2050. Thus, the rising aging population is a significant driver for the high-flow ventilators market.

Leading companies in the high-flow ventilator market are focusing on the development of advanced high-flow oxygen therapy ventilators to improve patient care, enhance respiratory support efficiency, and cater to the rising demand for versatile and user-friendly devices in healthcare environments. Advanced high-flow oxygen therapy ventilators are specialized machines that provide a greater flow of oxygen to patients, thereby improving oxygenation and respiratory support, especially in cases of acute respiratory failure or situations that require enhanced ventilation. For example, in October 2024, Nihon Kohden America, a medical technology firm based in the US, launched the NKV-440, which aims to tackle healthcare challenges such as staffing shortages and budget limitations while ensuring broader access to dependable respiratory solutions for healthcare providers. This innovative system is designed to meet the increasing demand for flexible ventilators in the current healthcare landscape.

Key players in the high-flow ventilator market are focusing on creating innovative solutions, such as humidified high-flow therapies, to improve patient comfort, enhance respiratory outcomes, and offer versatile treatment options for various patient needs. Humidified high-flow therapies deliver warm, moist air or oxygen at higher flow rates, which enhances comfort and supports lung function by reducing airway resistance and preventing dryness. Heated humidification adds moisture to the air provided to patients, further improving comfort and respiratory function by keeping airways moist. For example, in August 2024, Fisher & Paykel Healthcare Corporation, a medical technology company based in New Zealand, introduced the F&P my820 System, designed to improve respiratory care at home. This system aims to enhance care and outcomes for patients receiving mechanical ventilation in non-hospital settings, addressing the increasing demand for effective respiratory support outside of healthcare facilities. Its primary goal is to provide high-quality heated humidification for both adult and pediatric patients, ensuring they receive effective respiratory care even after discharge from the hospital.

In September 2022, Sentec, a Switzerland-based provider of non-invasive monitoring solutions, completed the acquisition of Percussionaire for an undisclosed amount. This acquisition allowed Sentec to expand its respiratory monitoring product lines by incorporating Percussionaire's TRUE-IPV technology. Percussionaire, a US-based specialty ventilation company, specializes in the development, manufacturing, and marketing of products used in respiratory care, including flow ventilators.

Major companies operating in the high flow ventilators market include ResMed Inc., Hamilton Medical AG, Hersill SL, ZOLL Medical Corporation, Percussionaire Corporation, Vyaire Medical Inc., Koninklijke Philips NV, Medtronic Plc, Acutronic Medical Systems AG, Essex Industries Inc., Getinge AB, Drägerwerk AG & Co KGaA, Fisher & Paykel Healthcare Corporation Limited, Metan Co. Ltd., Intersurgical Ltd., Laerdal Medical AS, Magnamed Tecnologia Médica S.A., Medin Medical Innovations GmbH, Mercury Medical LLC, Mindray Medical International Limited, Nihon Kohden Corporation, O-Two Medical Technologies Inc., Pulmodyne Systems Inc., Sechrist Industries Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Smiths Group plc, SunMed Equipment Co. Ltd., Ventec Life Systems Inc., Weihai Strongmedical Sci-Tech. Co. Ltd., Westmed Inc.

North America was the largest region in the high flow ventilators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global high flow ventilators market report during the forecast period. The regions covered in the high flow ventilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high flow ventilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

High flow ventilators are a form of respiratory support that delivers humidified oxygen at a flow rate higher than traditional oxygen therapy. These ventilators are commonly utilized in the treatment of patients with respiratory conditions such as chronic obstructive pulmonary disease (COPD) and other respiratory ailments.

The main types of high flow ventilators include portable high flow ventilators and trolley-mounted high flow ventilators. Portable high-flow ventilators are medical devices designed to administer high-flow oxygen therapy to patients in need of respiratory assistance. These ventilators use various interfaces, both invasive and non-invasive, and find applications in hospitals, ambulatory surgical centers, specialty clinics, long-term care centers, and other healthcare settings.

The high flow ventilators market research report is one of a series of new reports that provides high flow ventilators market statistics, including high flow ventilators industry global market size, regional shares, competitors with a high flow ventilators market share, detailed high flow ventilators market segments, market trends and opportunities, and any further data you may need to thrive in the high flow ventilators industry. This high flow ventilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The high flow ventilators market consists of sales of high flow ventilator machines, humidification systems, nasal cannulas, breathing circuits, and filters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.